COVID-19 vaccination in Djibouti

COVID-19 vaccination in Djibouti
CauseCOVID-19 pandemic

COVID-19 vaccination in Djibouti is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Djibouti began its vaccination program on 15 March 2021, initially with 24,000 doses of AstraZeneca's Covishield vaccine provided through COVAX.[1]

History

Timeline

March 2021

By the end of the month 455 vaccine doses had been administered.

April 2021

By the end of the month 11,343 vaccine doses had been administered.

May 2021

By the end of the month 14,943 vaccine doses had been administered.

June 2021

By the end of the month 35,606 vaccine doses had been administered.

August 2021

By the end of the month 54,229 vaccine doses had been administered.

September 2021

By the end of the month 67,229 vaccine doses had been administered.

October 2021

By the end of the month 92,097 vaccine doses had been administered while 7% of the targeted population had been fully vaccinated.

November 2021

By the end of the month 99,679 vaccine doses had been administered while 7% of the targeted population had been fully vaccinated.

December 2021

By the end of the month 200,309 vaccine doses had been administered while 23% of the targeted population had been fully vaccinated.

January 2022

By the end of the month 213,820 vaccine doses had been administered while 25% of the targeted population had been fully vaccinated.

Progress

Cumulative vaccinations in Djibouti[2]

References

  1. ^ Alliod, Marie-Pierre (6 April 2021). "Djibouti launched its COVID-19 vaccination campaign". P4H. Retrieved 12 May 2021.
  2. ^ "owid/covid-19-data". GitHub. Retrieved 7 March 2021.

Media files used on this page

SARS-CoV-2 (Wikimedia colors).svg
Author/Creator: Geraki, Licence: CC BY-SA 4.0
SARS-CoV-2 logo in Wikimedia colors
SARS-CoV-2 (CDC-23312).png
This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV). Note the spikes that adorn the outer surface of the virus, which impart the look of a corona surrounding the virion, when viewed electron microscopically. This virus was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China.